NDC product
RIFAMPIN
NDC 24658-802 · PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Key facts
| Product NDC | 24658-802 |
|---|---|
| Proprietary name | RIFAMPIN |
| Nonproprietary name | rifampin |
| Substances | RIFAMPIN |
| Dosage form | CAPSULE |
| Route | ORAL |
| Labeler | PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA064150 |
| Pharmacologic classes | Rifamycin Antibacterial [EPC], Rifamycins [CS] |
| Marketing start | Mar 14, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: